Elizabeth Reczek
Vorstandsvorsitzender bei Neutron Therapeutics, Inc.
Profil
Elizabeth Reczek is currently the Chief Executive Officer & Director at Neutron Therapeutics, Inc. She was previously the President & Chief Executive Officer at Excelimmune, Inc. and the Chief Executive Officer & Director at SeqLL, Inc. Reczek received an undergraduate degree from Harvard University and a doctorate degree from Massachusetts Institute of Technology.
Aktive Positionen von Elizabeth Reczek
| Unternehmen | Position | Beginn |
|---|---|---|
Neutron Therapeutics, Inc.
 Neutron Therapeutics, Inc. Medical DistributorsDistribution Services Neutron Therapeutics, Inc. is a private company that specializes in providing accelerator-based boron neutron capture therapy (BNCT) systems for targeted radiation therapy of solid tumors. The company is based in Danvers, MA and was founded in 2015 by Bill Buckley and Ted Smick. The company's flagship product, the Nubeam® therapy platform, is a compact, in-hospital neutron source that offers a higher neutron flux compared to competing systems and meets stringent reference values published by the International Atomic Energy Agency. Elizabeth Reczek has been the CEO of the company since 2020. | Vorstandsvorsitzender | 14.12.2021 |
Ehemalige bekannte Positionen von Elizabeth Reczek
| Unternehmen | Position | Ende |
|---|---|---|
| ATLANTIC INTERNATIONAL CORP. | Vorstandsvorsitzender | - |
Excelimmune, Inc.
 Excelimmune, Inc. Miscellaneous Commercial ServicesCommercial Services Excelimmune, Inc. provides laboratory and biotechnology services. It is a biopharmaceutical company specializing in the development of recombinant polyclonal antibodies to create novel therapies for treating disease in humans. The firm’s next generation technology is applicable to the treatment of diseases and infections caused by common bacteria, disease-causing proteins and viral pathogens. The company was founded in 2006 by Quinton Y. Zondervan and Vincent W. Coljee and is headquartered in Lexington, MA. | Vorstandsvorsitzender | - |
Ausbildung von Elizabeth Reczek
| Harvard University | Undergraduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ATLANTIC INTERNATIONAL CORP. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Excelimmune, Inc.
Excelimmune, Inc. Miscellaneous Commercial ServicesCommercial Services Excelimmune, Inc. provides laboratory and biotechnology services. It is a biopharmaceutical company specializing in the development of recombinant polyclonal antibodies to create novel therapies for treating disease in humans. The firm’s next generation technology is applicable to the treatment of diseases and infections caused by common bacteria, disease-causing proteins and viral pathogens. The company was founded in 2006 by Quinton Y. Zondervan and Vincent W. Coljee and is headquartered in Lexington, MA. | Commercial Services |
Neutron Therapeutics, Inc.
Neutron Therapeutics, Inc. Medical DistributorsDistribution Services Neutron Therapeutics, Inc. is a private company that specializes in providing accelerator-based boron neutron capture therapy (BNCT) systems for targeted radiation therapy of solid tumors. The company is based in Danvers, MA and was founded in 2015 by Bill Buckley and Ted Smick. The company's flagship product, the Nubeam® therapy platform, is a compact, in-hospital neutron source that offers a higher neutron flux compared to competing systems and meets stringent reference values published by the International Atomic Energy Agency. Elizabeth Reczek has been the CEO of the company since 2020. | Distribution Services |
